TRPH-222 / BMS, Triphase Accelerator Corporation, Catalent  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TRPH-222 / Triphase Accelerator Corporation, BMS
NCT03682796: Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma

Completed
1
32
Canada, US
TRPH-222
Triphase Research and Development III Corp.
Lymphoma, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell, Lymphoma, Marginal Zone, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular
11/21
11/21

Download Options